Joel Greenblatt Regenxbio Inc. Transaction History

Gotham Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$19.35 - $35.04 $160,779 - $291,147	-8,309 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$24.62 - $34.31 $204,567 - $285,081	8,309 New	8,309 $276,000
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $847,098 - $1.2 Million	-20,169 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$40.82 - $62.45 $68,536 - $104,853	-1,679 Reduced 7.68%	20,169 $1.16 Million
Q4 2018 Feb 14, 2019	SELL	$39.11 - $75.15 $1.2 Million - $2.3 Million	-30,643 Reduced 58.38%	21,848 $917,000

Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $1.48 Million - $1.87 Million	22,763 Added 76.57%	52,491 $3.96 Million
Q2 2018 Aug 14, 2018	BUY	$27.2 - $74.35 $808,601 - $2.21 Million	29,728 New	29,728 $2.13 Million
Q4 2017 Feb 14, 2018	SELL	$26.0 - $34.6 $272,220 - $362,262	-10,470 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $188,460 - $344,986	10,470	10,470 $345,000

192

42.6M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $590M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.